Heart Failure-Inducible Gene Therapy Targeting Protein Phosphatase 1 Prevents Progressive Left Ventricular Remodeling

Yosuke Miyazaki(Yamaguchi University), Masunori Matsuzaki(Ube (Japan)), Hidekazu Aoyama(Yamaguchi University), Masahiko Hoshijima(University of California San Diego), Hideko Kasahara(University of Florida), Hiroki Aoki(Yamaguchi University), Koichi Yoshimura(Yamaguchi University), Makoto Inui(Yamaguchi University), Yasuhiro Ikeda(AstraZeneca (Netherlands)), Kozo Shiraishi(Yamaguchi University), Shizuka N. Fujimoto(Yamaguchi University)
PLoS ONE
April 27, 2012
10.1371/journal.pone.0035875
Cited by 37

Related Papers

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome
|Journal of the American College of Cardiology|2009|359
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|245
Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease
|European Heart Journal|2018|244
Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease
|Journal of Clinical Investigation|2000|167